Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colonic Neoplasms 2Colonic Polyps 1Breast Neoplasms 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Menthol × Clear all
NCT01855607 2024-07-11

Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Columbia University

Phase 2 Terminated
12 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT02588248 2022-04-19

MINT-C

University Hospitals Cleveland Medical Center

Phase 3 Terminated
82 enrolled 10 charts
Gastrointestinal

Colonic Neoplasms, Colonic Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡